111 related articles for article (PubMed ID: 26222643)
1. Management of toxicities following pelvic irradiation for gynaecological cancers.
Fernandes A; Bhuva NJ; Taylor A
Curr Opin Oncol; 2015 Sep; 27(5):405-11. PubMed ID: 26222643
[TBL] [Abstract][Full Text] [Related]
2. Prevention of radiation enteritis by intrapelvic breast prosthesis.
Tuech JJ; Chaudron V; Thoma V; Ollier JC; Tassetti V; Duval D; Rodier JF
Eur J Surg Oncol; 2004 Oct; 30(8):900-4. PubMed ID: 15336738
[TBL] [Abstract][Full Text] [Related]
3. Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management.
Hauer-Jensen M; Wang J; Boerma M; Fu Q; Denham JW
Curr Opin Support Palliat Care; 2007 Apr; 1(1):23-9. PubMed ID: 18660720
[TBL] [Abstract][Full Text] [Related]
4. Dose escalation of amifostine for radioprotection during pelvic accelerated radiotherapy.
Koukourakis MI; Kyrgias G; Panteliadou M; Papadopoulou A; Tsiarkatsi M; Papachristou E; Bebeli M
Am J Clin Oncol; 2013 Aug; 36(4):338-43. PubMed ID: 22643562
[TBL] [Abstract][Full Text] [Related]
5. Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators.
Huh JW; Tanksley J; Chino J; Willett CG; Dewhirst MW
Clin Cancer Res; 2020 Jul; 26(13):3079-3090. PubMed ID: 32098770
[TBL] [Abstract][Full Text] [Related]
6. Prevention and Management of Radiation-induced Late Gastrointestinal Toxicity.
Teo MT; Sebag-Montefiore D; Donnellan CF
Clin Oncol (R Coll Radiol); 2015 Nov; 27(11):656-67. PubMed ID: 26129746
[TBL] [Abstract][Full Text] [Related]
7. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
[TBL] [Abstract][Full Text] [Related]
8. Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?
White ID; Allan H; Faithfull S
Br J Cancer; 2011 Sep; 105(7):903-10. PubMed ID: 21897386
[TBL] [Abstract][Full Text] [Related]
9. Predicting late effects of pelvic radiotherapy: is there a better approach?
Wedlake LJ; Thomas K; Lalji A; Blake P; Khoo VS; Tait D; Andreyev HJ
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1163-70. PubMed ID: 20231077
[TBL] [Abstract][Full Text] [Related]
10. Does hyperbaric oxygen administration decrease side effect and improve quality of life after pelvic radiation?
Sidik S; Hardjodisastro D; Setiabudy R; Gondowiardjo S
Acta Med Indones; 2007; 39(4):169-73. PubMed ID: 18046062
[TBL] [Abstract][Full Text] [Related]
11. Bowel-sparing intensity-modulated radiotherapy (IMRT) for palliation of large-volume pelvic bone metastases: rationale, technique and clinical implementation.
Griffioen G; Dahele M; Jeulink M; Senan S; Slotman B; Verbakel WF
Acta Oncol; 2013 May; 52(4):877-80. PubMed ID: 23057486
[No Abstract] [Full Text] [Related]
12. Radiation enteritis.
Bismar MM; Sinicrope FA
Curr Gastroenterol Rep; 2002 Oct; 4(5):361-5. PubMed ID: 12228037
[TBL] [Abstract][Full Text] [Related]
13. Acute and late toxicity in radical radiotherapy for bladder cancer.
Majewski W; Tarnawski R
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):598-609. PubMed ID: 19632819
[TBL] [Abstract][Full Text] [Related]
14. Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy.
Wedlake LJ; Shaw C; Whelan K; Andreyev HJ
Aliment Pharmacol Ther; 2013 Jun; 37(11):1046-56. PubMed ID: 23611411
[TBL] [Abstract][Full Text] [Related]
15. Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists.
Henson CC; Andreyev HJ; Symonds RP; Peel D; Swindell R; Davidson SE
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):552-7. PubMed ID: 21550216
[TBL] [Abstract][Full Text] [Related]
16. Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy.
White EC; Murphy JD; Chang DT; Koong AC
Am J Clin Oncol; 2015 Dec; 38(6):564-9. PubMed ID: 24401668
[TBL] [Abstract][Full Text] [Related]
17. Bowel injury: current and evolving management strategies.
Hauer-Jensen M; Wang J; Denham JW
Semin Radiat Oncol; 2003 Jul; 13(3):357-71. PubMed ID: 12903023
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers.
Kuku S; Fragkos C; McCormack M; Forbes A
Br J Cancer; 2013 Sep; 109(6):1504-12. PubMed ID: 24002603
[TBL] [Abstract][Full Text] [Related]
19. Acute toxicity in pelvic radiotherapy; a randomized trial of conformal versus conventional treatment.
Carrie C; Ginestet C
Radiother Oncol; 1997 Sep; 44(3):295-6. PubMed ID: 9380830
[No Abstract] [Full Text] [Related]
20. Intensity-modulated radiation therapy for gynecologic cancers: pitfalls, hazards, and cautions to be considered.
Randall ME; Ibbott GS
Semin Radiat Oncol; 2006 Jul; 16(3):138-43. PubMed ID: 16814153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
